The company raised $54.5 million to make treatments that restore protein function in polycystic kidney disease ...

The executive order pushing a new “gold standard” of science is profoundly troublesome, as Leigh Krietsch Boerner describes ...

While their functions are diverse, myosins are similar in structure. NMII is so much like cardiac myosin, which keeps the ...

Shyra Gardai, chief scientific officer at the extracellular protein degradation start-up EpiBiologics, says Big Pharma’s recent interest in glue degraders is likely in anticipation of an ...

Pharmaceuticals Pharma’s memorable moments of 2024 The headlines and highlights that the C&EN team found noteworthy this year by Laura Howes ...

Hours spent on chemical reactions can’t be recycled. Let’s make sure we conserve the ultimate nonrenewable resource ...

Researchers have discovered a highly conserved post translational modification in the STING pathway that when inhibited stops ...

By sampling vapor from popular brands of e-cigarettes, researchers found concerningly high levels of toxic metals in the ...

The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...

A team of researchers is tapping into the ocean’s vast body of free-floating environmental DNA to catch blooms before they ...

Essentially, cereblon and its target proteins can change shape to form a complex with the cereblon, the target, and the ...

Waste gases from China’s huge industrial clusters offer another opportunity for turning CO 2 into chemicals. That’s the ...